| AstraZeneca AG - Bydureon BCise 2 mg, Depot-lnjektionssuspension in einem Autoinjektor | | 67503 | | 01 | | Bydureon BCise 2 mg | | Depot-lnjektionssuspension in einem Autoinjektor | | A10BJ01 | | Exenatide | | 24.09.2020 | | |
| | Composition | | exenatidum 2 mg, saccharum, poly(lactidum-co-glycolidum) 50/50 (0.40 - 0.49 dl/g), triglycerida media, ad suspensionem pro dosi. | | Packungsbestandteile | | | | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | 4 | 90.57 | 114.90 | B | SL | Yes |
|
|
